This site is intended for Healthcare Professionals only

PSNC 'forced' to go public on 'irritating' DH negotiations


PSNC 'forced' to go public on 'irritating' DH negotiations

PSNC not making progress in talks with DHSC, says Dukes

The Pharmaceutical Services Negotiating Committee is being forced to air grievances in public due to the unwillingness of policy makers to engage on key issues, chief executive Simon Dukes has said. 

In a recent blog post, Mr Dukes spoke of the negotiator’s “increasing irritation” at funding talks with the Department of Health and Social Care and NHS England.

“Despite our constant efforts, and more importantly the phenomenal work pharmacies have been doing all year, we are not making progress in our funding negotiations."

The Government’s unwillingness to reimburse Covid-19 costs means it is “in effect asking you to pay for the privilege” of seeing patients, he told contractors.  

Forced to go public

Mr Dukes said that in negotiations officials frequently demonstrate “a refusal… to treat pharmacies as the core part of the NHS that they are”.

“Others resist conversations about fair margins and value, focusing only on what they consider to be the bare minimum costs for service delivery.”

Officials are also known to delay funding decisions “for many months” before eventually presenting information to the PSNC “with a tight deadline for turnaround,” said Mr Dukes.

He commented: “I have been involved in many negotiations over the years and I have always believed that the best discussions take place in private.

“It saddens me that PSNC is being forced to be increasingly public about the situation we find ourselves in.”

He said the sector “must not be bullied” and that the negotiator “will continue to hold the NHS and Government to account privately for their decisions and processes – but we will also now say more in public alongside the other pharmacy bodies if we don’t get positive outcomes soon”.

Copy Link copy link button


Stay up to date with all the news, learning and insight in the world of pharmacy.